Hospital Outcomes: Intervention in Moderately III Patients - Full Text View

Purpose

To evaluate the utility of real time prognostic data (illness severity, stability and function) in the improvement of hospitalization morbidity, mortality, iatrogenic complications and length of stay.

Condition	Intervention
Moderately Ill Medical Inpatients at the Cornell Campus of the New York-Presbyterian Hospital	Behavioral: Early assessment and referral to ancillary care services vs. standard care

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Prevention, Randomized, Open Label, Uncontrolled, Single Group Assignment, Efficacy Study

Official Title:	Hospital Outcomes: Intervention in Moderately III Patients

Further study details as provided by Weill Medical College of Cornell University:

Primary Outcome Measures:

To evaluate the utility of real time prognostic data and in the improvement of hospitalization morbidity, mortality, iatrogenic complications, and length of stay.

Secondary Outcome Measures:

To evaluate resource allocation and efficiency of ancillary service delivery in aggregate cost and 3 month follow up in regards to hospital readmission, living environment, and utilization of social services.

Estimated Enrollment:	444
Study Start Date:	September 1998
Estimated Study Completion Date:	April 1999

Detailed Description:

To evaluate resource allocation and efficiency of ancillary service delivery in aggregate cost and 3 month follow up in regards to hospital readmission, living environment, and utilization of social services.

This is a randomized study which will compare the current Standard of Care in hospital to EARLY assessment and referrals with respect to social work services, rehabilitation, psychiatry, and nursing. In this study, the control group will receive the hospital support services provided under current system of delivery and allocation. The intervention group will not receive any new or different services not already provided to all patients at New York Presbyterian Hospital. The difference between the 2 groups will be the uniformity of screening to identify the needs of the patient in the respective area of social services, rehabilitation, psychiatric assistance, and nursing care, and the timeliness by which the referrals for support services will be placed.

Potential interventions: (In both control and experimental group)

Social work: Discharge planning (homecare, visiting nursing services, skilled nursing facility placement).
Rehabilitation: Physical Therapy (improve ADLs-activities of daily living).
Psychiatry: Diagnosis and Assistance in management of Depression.
Nursing: Prevention of in hospital falls and decubitus ulcer formation.

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

All medical in-patients who are coded moderately ill with fair to poor function in the SIGNOUT program will be asked to participate in our study.
Patients who are able to provide verbal consent for their participation will be enrolled.

Exclusion Criteria:

Any patient not coded in the SIGNOUT system as moderately ill with fair to poor function.
Patients who refuses not to participate in the study.
Patients who are unable to give written informed consent.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00256659

Locations


United States, New York
	New York Presbyterian Hospital- Weill Medical Center
	New York, New York, United States, 10021

Sponsors and Collaborators

Weill Medical College of Cornell University

Investigators


Principal Investigator:	Mary E Charlson, MD	Weill Medical College of Cornell University

Principal Investigator:	James Hollenberg, MD	Weill Medical College of Cornell University

Principal Investigator:	Mark Pecker, MD	Weill Medical College of Cornell University

Principal Investigator:	Sona Euster, MSW	Weill Medical Center of Cornell University

Principal Investigator:	Delia Gorga, PhD	Weill Medical Center of Cornell University

Principal Investigator:	Mary Cooper, MD	Weill Medical College of Cornell University

More Information

Responsible Party:	Weill Cornell Medical College ( Mary E. Charlson, MD )
Study ID Numbers:	9808003482
First Received:	November 17, 2005
Last Updated:	March 31, 2008
ClinicalTrials.gov Identifier:	NCT00256659
Health Authority:	United States: Institutional Review Board

Keywords provided by Weill Medical College of Cornell University:

Medical inpatients

Social Work

Physical therapy

Occupational therapy

Psychiatry

Early intervention

Iatrogenic complications

ClinicalTrials.gov processed this record on September 19, 2008

Sponsored by:	Weill Medical College of Cornell University
Information provided by:	Weill Medical College of Cornell University
ClinicalTrials.gov Identifier:	NCT00256659